PlainRecalls
FDA Devices Moderate Class II Ongoing

VITROS Immunodiagnostic Products High Sample Diluent A Reagent Pack

Reported: January 26, 2022 Initiated: November 22, 2021 #Z-0503-2022

Product Description

VITROS Immunodiagnostic Products High Sample Diluent A Reagent Pack

Reason for Recall

Lower than expected results for VITROS¿ Immunodiagnostic Products TSH Reagent Pack when diluted with VITROS¿ Immunodiagnostic Products High Sample Diluent A Reagent Pack Lot 2190.

Details

Units Affected
1416 units
Distribution
Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, DC, DE, FL, GA, IA, IL, IN, KY, LA, MD, ME, MI, MO, MS, MT, NC, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WI, WV and the countries of Australia, Brazil, Canada, Chile, China, Colombia, India, Japan, Mexico, Singapore, United Kingdom, France, Germany, Italy, Spain, Portugal, Russia, Denmark, Norway, Sweden, Belgium, The Netherlands.
Location
Rochester, NY

Frequently Asked Questions

What product was recalled?
VITROS Immunodiagnostic Products High Sample Diluent A Reagent Pack. Recalled by Ortho-Clinical Diagnostics, Inc.. Units affected: 1416 units.
Why was this product recalled?
Lower than expected results for VITROS¿ Immunodiagnostic Products TSH Reagent Pack when diluted with VITROS¿ Immunodiagnostic Products High Sample Diluent A Reagent Pack Lot 2190.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 26, 2022. Severity: Moderate. Recall number: Z-0503-2022.